Both these companies are edging higher on the NASDAQ. Thoratec is approaching 52 week high's as the FDA is assessing the Heartmate II which will open up the market even more. This will ultimately help VCR's cause too.
Abiomed went up more than 12% overnight....another heart device company with favourable analysts recommendations.
I dont think the market here in OZ fully understands the position of VCR and how close they are to capturing a good market share in this multi billion dollar industry.
To find out more about Thoratec and Abiomed go to the NASDAQ site and typr in THOR and ABMD.
VCR Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
